Wang Hui, George Graeme, Bartlett Selena, Gao Changyou, Islam Nazrul
Pharmacy Discipline, School of Clinical Sciences, Queensland University of Technology, Brisbane, QLD, Australia; Institute of Health Biomedical Innovation (IHBI), Queensland University of Technology, Brisbane, QLD, Australia.
Institute of Health Biomedical Innovation (IHBI), Queensland University of Technology, Brisbane, QLD, Australia; School of Chemistry, Physics and Mechanical Engineering, Science and Engineering Faculty, Queensland University of Technology, Brisbane, QLD, Australia.
Eur J Pharm Biopharm. 2017 Apr;113:118-131. doi: 10.1016/j.ejpb.2016.12.023. Epub 2017 Jan 11.
This study reports the development of nanoparticles in the form of inhalable micro-aggregates of biodegradable chitosan (CS) loaded with nicotine hydrogen tartrate (NHT) for potential pulmonary delivery of nicotine from dry powder inhaler (DPI) formulations with prolonged release profile. The NHT-loaded CS particles were prepared using a water-in-oil emulsion crosslinking method. The prepared particles were characterized using scanning electron microscopy (SEM) and transmission electron microscopy (TEM) for morphological studies; Zetasizer and Mastersizer were applied for particle size analysis. The in vitro aerosolization of the formulations was studied using a twin-stage-impinger (TSI) and promising aerosolization characteristics were shown. The nanoparticles were spherical with size ranges between 167 and 411nm while micro-aggregates (3.73-4.73μm) were formed among nanoparticles. According to differential scanning calorimetry (DSC), X-ray diffraction (XRD) analysis and attenuated total reflectance-Fourier transform infrared (ATR-FTIR) spectroscopy, the NHT crystallinity was lost when in the particles, indicating it was uniformly dispersed as a solid solution. On the basis of X-ray photoelectron spectroscopy (XPS) analysis, the amount of NHT loaded on the surface of CS increased proportionally with increasing drug loading in the bulk so there was no surface enhancement. The fine particle doses (FPD) of NHT ranging between 1.7 and 3.2mg from DPI formulations were concentration dependent and increased with increased drug loading. Based on the in vitro release study, NHT released from CS particles with a burst release in the first 8h and subsequent prolonged release of nicotine.
本研究报告了以可生物降解壳聚糖(CS)的可吸入微聚集体形式存在的纳米颗粒的开发情况,该微聚集体负载有酒石酸氢尼古丁(NHT),用于通过具有延长释放曲线的干粉吸入器(DPI)制剂实现尼古丁的潜在肺部递送。采用油包水乳液交联法制备了负载NHT的CS颗粒。使用扫描电子显微镜(SEM)和透射电子显微镜(TEM)对制备的颗粒进行形态学研究表征;使用Zetasizer和Mastersizer进行粒度分析。使用双级撞击器(TSI)研究了制剂的体外雾化情况,并显示出良好的雾化特性。纳米颗粒呈球形,尺寸范围在167至411nm之间,而在纳米颗粒之间形成了微聚集体(3.73 - 4.73μm)。根据差示扫描量热法(DSC)、X射线衍射(XRD)分析和衰减全反射 - 傅里叶变换红外(ATR - FTIR)光谱,NHT在颗粒中时结晶度丧失,表明它作为固溶体均匀分散。基于X射线光电子能谱(XPS)分析,CS表面负载的NHT量与本体中药物负载量的增加成比例增加,因此不存在表面增强现象。DPI制剂中NHT的细颗粒剂量(FPD)在1.7至3.2mg之间,与浓度有关,并随药物负载量的增加而增加。基于体外释放研究,NHT从CS颗粒中在最初8小时内突发释放,随后尼古丁持续释放。